Overview


According to FutureWise analysis the market for acute pancreatitis is expected to register a CAGR of 5.29% from 2023-2031.

Pancreatitis is inflammation of the pancreas. It can either be acute, in which short-term inflammation develops suddenly or chronic, in which it is reoccurring or persistent. Inflammation is an immune system activity that can cause swelling, pain, and changes in how an organ or tissue works. The pancreas is a long, flat gland behind the stomach in the upper abdomen. The pancreas regulates the body digest food and regulates blood sugars. The damage to the pancreas can get worse over time. Acute pancreatitis may improve on its own. More serious disease requires treatment in a hospital and can cause life-threatening complications.

The most common factors of acute pancreatitis are gallstones, excessive alcohol consumption, and other use of certain medications. Gallstones are small stones that form in the gallbladder. They trigger acute pancreatitis if they move out of the gallbladder and block the entrance of the pancreas. This entraps the enzymes inside the pancreas. As pressure builds up after the obstruction, it activates the enzymes inside the pancreas and starts digesting the pancreas itself. This induces the inflammatory response of gallstone pancreatitis. Excessive alcohol use is another clear cause of pancreatitis. It may be that the toxic byproducts of alcohol in the blood cause an inflammatory response in the pancreas, or they somehow chemically activate the digestive enzymes inside the pancreas. 

FutureWise Market Research has published a report that provides an insightful analysis acute pancreatitis market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, acute pancreatitis market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • CalciMedica
  • SCM Lifescience
  • Samsung Bioepis
  • GNT Pharma Co.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • General Electric Company
  • Medtronic
  • Boston Scientific Corporation
  • Fresenius Kabi USA

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Acute Pancreatitis Market:

  • In December 2022, CalciMedica, Inc. is conducting a Phase II clinical dose-ranging study of Auxora in patients with acute pancreatitis and attending systemic inflammatory response syndrome.

  • In March 2022, AcelRx Pharmaceuticals, Inc. presented comparative data between two different dialysis circuit anticoagulants, Nafamostat and citrate anticoagulation (RCA), in pediatric patients undergoing continuous renal replacement therapy (CRRT). Nafamostat is a serine protease inhibitor used to treat acute pancreatitis.

The rising incidence of acute pancreatitis conditions, such as alcohol use, prevalent gallstones, and other medical use, is anticipated to boost the growth of the acute pancreatitis market over the projection period. This increase in cases has triggered an increased demand for advanced diagnostic tools and innovative treatment options, emphasizing the need for continuous research and development efforts in this field. In addition, the research and development efforts of pharmaceutical companies and other research institutes may increase the demand for acute pancreatitis. These initiatives focus on inventing more potent and targeted drugs for addressing this condition. This includes a range of pharmaceutical solutions, varying from advanced pain management drugs to potent anti-inflammatory agents. Therefore, intensified R&D activities are expected to drive market growth. Moreover, recent trends in treating acute pancreatitis have prioritized early treatments and multidisciplinary practice. Rapid diagnosis and immediate initiation of fluid resuscitation have become critical, improving patient outcomes. Also, there's a growing recognition of the vital role of personalized nutritional support in reducing complications and expediting recovery, further propelling the growth of the acute pancreatitis market. However, the potential complications from acute pancreatitis present significant restraints in its management. Conditions like pseudocysts and abscesses may require prolonged hospital stays and high treatment costs. Also, the risk of organ failure adds a critical complexity factor to patient care. This exacerbates the medical challenge and increases the economic burden on healthcare systems, further hindering the market growth over the forecast period.

By Cause

  • Gallstones
  • Alcohol
  • Others

By Treatment and Diagnosis

  • Treatment
    • Intravenous Fluid
    • Analgesics
    • Nutritional Support
    • Endoscopic Retrograde Cholangiopancreatography (ERCP)
    • Others
  • Diagnosis
    • Imaging Tests
    • Laboratory Tests

By End User

  • Hospitals and Clinicss
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia-Pacific registered highest share in the market in 2022. Owing to the increasing population of individuals suffering from acute pancreatitis, the increasing number of obesity and gallstone cases, the increasing number of research studies, the presence of a well-developed healthcare infrastructure, increasing research and development R&D activities and high healthcare spending are factors contributing to the market's growth in the region. In addition, the rising prevalence of obesity among the population due to their changing lifestyles has increased the risk of developing pancreatic inflammation, which is anticipated to fuel market growth. For instance, as per the article by the NLM, in November 2022, acute pancreatitis will be the most prevalent gastrointestinal condition and the main reason for hospitalization in the US. Therefore, the above-mentioned factors will likely boost market growth over the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Acute Pancreatitis Market By Cause, By Treatment and Diagnosis, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Acute Pancreatitis Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Acute Pancreatitis Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Acute Pancreatitis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Acute Pancreatitis Market, By Cause Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Gallstones
        2. Alcohol
        3. Others

  • 8.   Acute Pancreatitis Market, By Treatment and Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Treatment
         1.1. Intravenous Fluid
         1.2. Analgesics
         1.3. Nutritional Support
         1.4. Endoscopic Retrograde Cholangiopancreatography (ERCP)
         1.5. Others
        2. Diagnosis
         2.1. Imaging Tests
         2.2. Laboratory Tests

  • 9.   Acute Pancreatitis Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and Clinics
        2. Others

  • 10.   North America Acute Pancreatitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Acute Pancreatitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Acute Pancreatitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Acute Pancreatitis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. CalciMedica
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. SCM Lifescience
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Samsung Bioepis
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GNT Pharma Co.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Baxter International Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. General Electric Company
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Boston Scientific Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Fresenius Kabi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Pancreatitis Market

Read More

Pancreatic Cancer Market

Read More

Pancreatic Cancer Drugs Market

Read More
Partner

Our Clients